Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

Annals of neurology·2026
Same author

Combining plasma biomarkers and cognitive challenge tests enhances prediction of functional trajectories of decline among older adults with cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same author

Apathy in dementia with Lewy bodies: Frequency, correlates, and impact on patient and caregiver experiences.

Parkinsonism & related disorders·2026
Same author

Exposure to Air Pollutants and Lewy Body and Parkinson Disease-Related Dementias.

JAMA network open·2026
Same author

Diffusion MRI and α-Synuclein Seed Amplification Status in Parkinson's Disease.

Annals of neurology·2026
Same author

Cognitive Fluctuations, Neuropsychiatric Burden, and Quality of Life in Moderate-Advanced Dementia With Lewy Bodies: The Role of Dysautonomia.

Neurology·2026
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Babak Ahmadi1,2, Zohreh Morshedizad1,2, Hojjatollah Sadeqi1,2

  • 1University of Florida, Gainesville, FL, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

同时发生的阿尔茨海默氏症 (AD) 和勒维体 (LB) 病理加速大脑衰老,比单独出现的任何一种疾病都要多. 这凸显了对这些复杂的神经退行性疾病的综合生物标志物测定和向治疗的需要.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物 生物标志物
  • 神经成像是一种神经成像.

背景情况:

  • 阿尔茨海默病 (AD) 和莱维体 (LB) 病理常常并存,但它们对大脑衰老,缩和功能的综合影响尚未得到充分理解.
  • 在α-synuclein种子放大试验 (SAA) 的进步允许体内检测LB病理,提供新的途径研究其与AD的相互作用.

研究的目的:

  • 研究AD和LB病理同时发生在大脑衰老,缩和认知功能上的协同效应.
  • 利用深度学习 (DL) 模型和种子放大试验 (SAA) 来量化具有明显AD和LB病理特征的个体的神经退行.

主要方法:

  • 一个3D-DenseNet深度学习模型被训练在4,355个认知正常的个体的结构性MRI数据上,以估计大脑年龄.
  • 在803名认知障碍参与者中,α-synuclein阳性由CSFSAA确定,AD阳性由p-tau181/Aβ42比率确定,将他们分为AD-LB-,AD-LB+,AD+LB-和AD+LB+亚组.
  • 在四个病理学子组中,纵向分析了大脑年龄差距,区域特异性缩和认知表现.

主要成果:

  • AD+LB+亚组表现出最大的脑年龄差距,明显超过单一病理组的脑年龄差距,表明脑衰老加速.
  • 性别分层分析揭示了性别依赖的脆弱性,男性在AD-亚组和AD+亚组的女性中显示出更高的大脑年龄差距.
  • 由DL驱动的突出性地图突出显示了AD+LB+中枢时,头和基底腺区域的明显神经退行,与加速缩和最严重的认知缺陷相关.

结论:

  • 同时发生的AD和LB病理协同增强神经退行并加速大脑衰老.
  • 这些发现强调了联合生物标志物测试对于诊断和管理患有AD和LB病理同时存在的个体的关键重要性.
  • 针对性干预对于解决AD和LB病理综合症患者观察到的放大神经退行性影响至关重要.